Compound Potassium Hydrogen Phosphate Injection
Formulation (FDF) · Injection · 5ml containing 1.2g potassium dihydrogen phosphate and 1.18g dipotassium hydrogen phosphate (as K₂HPO₄)
Formulation (FDF)Confidentiality：Public
- INN / Generic Name
- Compound Potassium Hydrogen Phosphate Injection
- Dosage Form
- Injection
- Strength
- 5ml containing 1.2g potassium dihydrogen phosphate and 1.18g dipotassium hydrogen phosphate (as K₂HPO₄)
- Therapy Area
- Gastroenterology & Hepatology
- Indication
- Hypophosphataemia; Parenteral nutrition
- Current Status
- Official FDF licensing catalog (UB552)
- GMP Certification
- CN - NMPA
- CEP
- No
- DMF Type
- —
- Stability Data
- —
- BE Required
- Not required / waivable
- Registration Pathway
- Registered (market rights transferable / DCP·NP per market)
- MOQ
- On request
- Lead Time
- On request
- Price Range
- On request
HS Code
3004.903 customs bills on file
Registrable Markets
China
Process / Sequence / Exact Price
- Process Summary
- —
- Exact Price